Our round-up of biotech financings is led this week by Braveheart Bio, a San Francisco biotech that has launched with $185 million, a lead drug for hypertrophic cardiomyopathy (HCM), and Biogen CEO ...
These children have been inspirational during their illnesses - and have now received Braveheart awards from a leading ...
The acclaimed actor, whose sisters rallied to care for him as a child, is campaigning against cuts to the Adoption and Special Guardianship Support Fund ...
In today’s world of seemingly endless streaming platforms and bundles, shopping for the right one(s) can be a trying ordeal. Since so many have their own expansive media libraries, it can be hard to ...
This article is regularly updated to include the latest deals available. Nowadays, you’d be hard-pressed to find someone without at least one streaming service, but multiple streaming services can add ...
With $185 million in series A funding and an army of experienced leaders in its ranks, Braveheart Bio is setting off to joust with big names in an emerging heart disease drug arena. Backed by ...
Board to include Chris Viehbacher as Chair, with investor syndicate led by Andreessen Horowitz, Forbion, and OrbiMed with participation from Enavate Sciences (a platform of Patient Square Capital) and ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min It’s one of the largest ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
WASHINGTON (AP) — Colorado voters approved a ballot measure on Tuesday that would raise state income taxes on households earning at least $300,000 annually to fund free meals for all public school ...
NEW YORK CITY – Curtis Sliwa says he’s charging into the final stretch of New York City’s mayoral race like "Braveheart" — confident, defiant and ready to die on his sword for the city he loves. In an ...